Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
- Status
- RECRUITING
- Phase
- NA
Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study
- Status
- RECRUITING
- Phase
- NA
Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
- Status
- UNKNOWN
- Phase
- NA
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2